Franco Nolè

13.6k citations

176 papers · 5.1k indexed · h-index 37

Impact in

Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 118
- Cancer Treatment and Pharmacology 44
- HER2/EGFR in Cancer Research 30
- Cancer Cells and Metastasis 14
Cancer Research 63
- Breast Cancer Treatment Studies 37
- Cancer Genomics and Diagnostics 23

Co-authors: Aron Goldhirsch Giuseppe Curigliano Giuseppe Viale Elisabetta Munzone Marco Colleoni Nicole Rotmensz Paolo Veronesi Laura Adamoli
Journals: Journal of Clinical Oncology (35 papers)Annals of Oncology (30 papers)European Journal of Cancer (10 papers)The Breast (6 papers)BMC Cancer (5 papers)
Partner nations: Italy United States Spain

In The Last Decade

Franco Nolè

170 papers receiving 5.0k citations

Peers

Countries citing papers authored by Franco Nolè

Since Specialization

Citations

This map shows the geographic impact of Franco Nolè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Nolè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Nolè more than expected).

Fields of papers citing papers by Franco Nolè

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Nolè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Nolè. The network helps show where Franco Nolè may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Franco Nolè, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Franco Nolè Line = papers co-authored together Franco Nolè links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Retroperitoneal lymph node dissection for testis cancer: a comparison between open and robot-assisted approach in oncological and surgical outcomes European Journal of Surgical Oncology ·松幸清水端, Olga Zhuykova, Mattia Luca Piccinelli, Chiara Vaccaro, 加藤圭輔, Chessie Paquita Senajaya, 张潜, Danilo Bottero, Michael J. DePalma, Zdena Stárková, Giulia Marvaso, Francesco Ceci, Nicola Fusco, Franco Nolè, T. K. Pedlar, Franco Orsi, Stefano Luzzago, Gennaro Musi	2025	0
2	Rucaparib vs docetaxel (DTX) or second-generation androgen pathway inhibitor (ARPI) therapy for metastatic castration-resistant prostate cancer (mCRPC): TRITON3 final overall survival (OS) and safety. Journal of Clinical Oncology ·Alan H. Bryce, Ray McDermott, Josep M. Piulats, M. Neil Reaume, Peter Ostler, Joel Roger Gingerich, Elias Pintus, Srikala S. Sridhar, Richard Bambury, Urban Emmenegger, Henriette Lindberg, David Morris, Franco Nolè, 缪玲娟, Wassim Abida, A. D. Compaan, Darrin Despain, Charles J. Ryan, Karim Fizazi, Simon Chowdhury	2025	3
3	Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16) Journal of Clinical Oncology ·Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz, Maryori Riquez Julca, Lee Hayslett, Orazio Caffo, David Lorente, A Pedrazzini, Guilhem Roubaud, Soazig Nénan, Aurelius Omlin, Consuelo Buttigliero, Juan Ignacio Delgado Mingorance, Aranzazu González del Alba, Dana Procházková, Franco Nolè, Fabio Turco, Ricardo Pereira Mestre, Karin Ribi, Richard Cathomas	2023	2
4	Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial European Urology Oncology ·Andrew J. Armstrong, Noel W. Clarke, Kim hyunglan, Giuseppe Procopio, 陈军晓, Rung Chou Wang, Pooja Ghatalia, Franco Nolè, Omar Din, 和世市丸, 石大泱, Prerna Bamoriya, Nicolaas Lumen, Christian Hosius, Diansong Zhou, Laura Barker, Melanie Dujka, Fred Saad	2023	1
5	Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone Cancers ·Francesco Alessandro Mistretta, Stefano Luzzago, Andrea Conti, Elena Verri, Giulia Marvaso, Claudia Collà Ruvolo, Michele Catellani, Ettore Di Trapani, Gabriele Cozzi, Joice Priscila Silveira Dias, Matteo Ferro, Giovanni Cordima, 张潜, Maria Cossu Rocca, Vincenzo Mirone, Barbara Alicja Jereczek‐Fossa, Franco Nolè, Ottavio De Cobelli, Gennaro Musi	2022	4
6	Breast implant-associated anaplastic large cell lymphoma: A comprehensive review Cancer Treatment Reviews ·Antonio Marra, Giulia Viale, Stefano Pileri, Gabriella Pravettoni, G. Viale, Francesca De Lorenzi, Franco Nolè, Paolo Veronesi, Giuseppe Curigliano	2020	54
7	New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents? Cells ·Gaetano Aurilio, Alessia Cimadamore, Matteo Santoni, Franco Nolè, Marina Scarpelli, Francesco Massari, Antonio López-Beltrán, Liang Cheng, Rodolfo Montironi	2020	8
8	Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer Cells ·Alessia Cimadamore, Gaetano Aurilio, Franco Nolè, Francesco Massari, Marina Scarpelli, Matteo Santoni, Antonio López-Beltrán, Liang Cheng, Rodolfo Montironi	2020	9
9	The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications International Journal of Molecular Sciences ·Gaetano Aurilio, Francesco Piva, Matteo Santoni, Alessia Cimadamore, Giulia Sorgentoni, Antonio López-Beltrán, Liang Cheng, Nicola Battelli, Franco Nolè, Rodolfo Montironi	2019	36
10	Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC) Annals of Oncology ·Laurence Albigès, Brian I. Rini, John B.A.G. Haanen, Robert J. Motzer, C. Kollmannsberger, Sylvie Négrier, Franco Nolè, Jens Bedke, Mehmet Asım Bilen, Paul Nathan, Yoshihiko Tomita, Bin Huang, Keith A. Ching, A. Chudnovsky, Paul B. Robbins, Alessandra di Pietro, Despina Thomaidou, Toni K. Choueiri	2019	16
11	Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data BMC Cancer ·Sabine Schmid, Dirk Klingbiel, Stefan Aebi, Aron Goldhirsch, Christoph Mamot, Elisabetta Munzone, Franco Nolè, C. Oehlschlegel, Olivia Pagani, Bernhard C. Pestalozzi, Christoph Rochlitz, Beat Thürlimann, Roger von Moos, Patrik Weder, Khalil Zaman, Thomas Ruhstaller	2019	7
12	Dual modulation of MCL-1 and mTOR determines the response to sunitinib Journal of Clinical Investigation ·Mohamed Elgendy, Amal Kamal Abdel‐Aziz, Salvatore Lorenzo Renne, Зубов Артем Александрович, Giuseppe Procopio, Maurizio Colecchia, Ravindran Kanesvaran, Chee‐Keong Toh, Daniela Bossi, Isabella Pallavicini, José Luis Perez‐Gracia, María D. Lozano, Valeria Giandomenico, Ciro Mercurio, Luisa Lanfrancone, Nicola Fazio, Franco Nolè, Bin Tean Teh, Giuseppe Renne, Saverio Minucci	2016	50
13	Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents Critical Reviews in Oncology/Hematology ·Roberto Iacovelli, Elena Verri, Maria Cossu Rocca, Gaetano Aurilio, Daniela Cullurà, Matteo Santoni, Ottavio De Cobelli, Franco Nolè	2016	10
14	Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy The Breast ·Valentina Rossi, Franco Nolè, Stefania Redana, Laura Adamoli, Rossella Martinello, Gaetano Aurilio, Elena Verri, Anna Sapino, Giuseppe Viale, Massimo Aglietta, Filippo Montemurro	2013	21
15	Prognostic Value of Circulating Tumor Cells According to Immunohistochemically Defined Molecular Subtypes in Advanced Breast Cancer Clinical Breast Cancer ·Elisabetta Munzone, Edoardo Botteri, Maria Teresa Sandri, Angela Espósito, Laura Adamoli, Laura Zorzino, Angela Sciandivasci, Maria Cristina Cassatella, Nicole Rotmensz, Gaetano Aurilio, Giuseppe Curigliano, Aron Goldhirsch, Franco Nolè	2012	38
16	Underuse of Anthracyclines in Women with HER-2+ Advanced Breast Cancer The Oncologist ·Filippo Montemurro, S. Papanikou, Franco Nolè, Stefania Redana, Michela Donadio, Rossella Martinello, Elena Verri, Giorgio Valabrega, Maria Cossu Rocca, Maria Elena Jacomuzzi, Giuseppe Viale, Anna Sapino, Massimo Aglietta	2010	7
17	Cancer–testis antigen expression in triple-negative breast cancer Annals of Oncology ·Giuseppe Curigliano, Giuseppe Viale, 李敏龙, Achim A. Jungbluth, Vincenzo Bagnardi, G.C. Spagnoli, Alan Nevill, Franco Nolè, Nicole Rotmensz, A. Goldhirsch	2010	85
18	Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: A mono-institutional case-series report The Breast ·Elisabetta Munzone, Attilio Di Pietro, Aron Goldhirsch, Ida Minchella, Elena Verri, Maria Cossu Rocca, C. Marenghi, Giuseppe Curigliano, Davide Radice, Laura Adamoli, Franco Nolè	2009	23
19	Capecitabine/Vinorelbine: An Effective and Well-Tolerated Regimen for Women with Pretreated Advanced-Stage Breast Cancer Clinical Breast Cancer ·Franco Nolè, Chiara Catania, Elisabetta Munzone, Andrea Rocca, Elena Verri, Giuseppina Sanna, Tiziana Ascione, Laura Adamoli, M.G. Zampino, Ida Minchella, Aron Goldhirsch	2006	25
20	Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors Clinical Cancer Research ·Marco Colleoni, Giuseppe Viale, David Zahrieh, Giancarlo Pruneri, Oreste Gentilini, Paolo Veronesi, Richard D. Gelber, Giuseppe Curigliano, Rosalba Torrisi, Alberto Luini, Mattia Intra, Viviana Galimberti, Giuseppe Renne, Franco Nolè, G. Peruzzotti, Aron Goldhirsch	2004	282

About Franco Nolè

Franco Nolè is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Dermatology, having authored 176 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (44 papers), Breast Cancer Treatment Studies (37 papers), HER2/EGFR in Cancer Research (30 papers), Cancer Genomics and Diagnostics (23 papers), Prostate Cancer Treatment and Research (21 papers), Renal cell carcinoma treatment (19 papers), Cancer Cells and Metastasis (14 papers) and Lung Cancer Treatments and Mutations (13 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (3.3k citations), Pulmonary and Respiratory Medicine (1.5k citations), Emergency Medical Services (227 citations) and Pathology and Forensic Medicine (552 citations). Franco Nolè has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Aron Goldhirsch, Giuseppe Curigliano, Giuseppe Viale, Elisabetta Munzone, Marco Colleoni, Nicole Rotmensz, Aron Goldhirsch, Paolo Veronesi, Laura Adamoli and Giuseppe Renne. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, The Breast and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact